Renal cell tumors convert natural killer cells to a proangiogenic phenotype.
angiogenesis
immunosuppression
innate immunity
kidney cancer
natural killer cells
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
30 Jun 2020
30 Jun 2020
Historique:
received:
27
03
2020
accepted:
05
06
2020
entrez:
14
7
2020
pubmed:
14
7
2020
medline:
14
7
2020
Statut:
epublish
Résumé
Natural killer (NK) cells are classically associated with immune surveillance and destruction of tumor cells. Inconsistent with this function, NK cells are found in advanced human tumors including renal cell carcinoma (RCC). NK cells with non-classical phenotypes (CD56
Identifiants
pubmed: 32655841
doi: 10.18632/oncotarget.27654
pii: 27654
pmc: PMC7335666
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2571-2585Subventions
Organisme : NCI NIH HHS
ID : R01 CA199649
Pays : United States
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Références
Cancer Lett. 2015 Apr 10;359(2):335-43
pubmed: 25641338
Semin Oncol. 2002 Jun;29(3 Suppl 7):41-6
pubmed: 12068388
Int J Cancer. 2014 Oct 15;135(8):1832-41
pubmed: 24615391
PLoS One. 2014 Jan 31;9(1):e87131
pubmed: 24498025
Hum Vaccin Immunother. 2015;11(7):1612-20
pubmed: 25996049
Int Immunopharmacol. 2013 Oct;17(2):198-204
pubmed: 23806302
J Immunol. 2013 Apr 15;190(8):3939-48
pubmed: 23487420
JAMA. 1994 Mar 23-30;271(12):907-13
pubmed: 8120958
Cancer Res. 2015 Aug 1;75(15):3098-107
pubmed: 26081809
J Urol. 1997 Apr;157(4):1482-6
pubmed: 9120987
J Immunol. 2004 Jun 15;172(12):7335-40
pubmed: 15187109
Reproduction. 2006 Aug;132(2):217-32
pubmed: 16885531
Cancer Cell. 2011 Apr 12;19(4):512-26
pubmed: 21481792
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):2007-9
pubmed: 2414257
J Immunol Res. 2017;2017:6915912
pubmed: 29423418
N Engl J Med. 1985 Dec 5;313(23):1485-92
pubmed: 3903508
Cytotherapy. 2003;5(3):259-72
pubmed: 12850795
Neoplasia. 2013 Feb;15(2):133-42
pubmed: 23441128
Blood. 2008 Mar 15;111(6):3108-15
pubmed: 18187664
Front Immunol. 2013 Dec 25;4:490
pubmed: 24400010
J Urol. 1996 Apr;155(4):1385
pubmed: 8632583
Cancer J. 2008 Sep-Oct;14(5):320-4
pubmed: 18836337
Urology. 1982 Aug;20(2):177-81
pubmed: 7112827
PLoS One. 2013 May 28;8(5):e64835
pubmed: 23724099
Nat Rev Cancer. 2002 Jan;2(1):38-47
pubmed: 11902584
Cancers (Basel). 2019 Apr 01;11(4):
pubmed: 30939820
J Immunol. 1995 Aug 1;155(3):1066-73
pubmed: 7636180
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2900-9
pubmed: 25991856
Front Immunol. 2017 Mar 16;8:293
pubmed: 28360915
Innate Immun. 2013 Feb;19(1):76-85
pubmed: 22781631
Nat Rev Cancer. 2006 Jul;6(7):506-20
pubmed: 16794634
PLoS One. 2017 Jun 9;12(6):e0179257
pubmed: 28598999
J Natl Cancer Inst. 2014 Sep 01;106(8):dju200
pubmed: 25178695
J Immunother Cancer. 2017 Sep 19;5(1):73
pubmed: 28923105
Clin Cancer Res. 2014 Aug 1;20(15):4096-106
pubmed: 24907113
Cytotherapy. 2005;7(1):16-22
pubmed: 16040380
Cancer Biol Ther. 2009 Feb;8(4):322-30
pubmed: 19305150
Oncotarget. 2016 Jan 26;7(4):4310-25
pubmed: 26713602
Cancer. 1995 Sep 1;76(5):824-32
pubmed: 8625186
Urol Clin North Am. 1993 May;20(2):303-21
pubmed: 8493752
Nature. 2000 Sep 14;407(6801):242-8
pubmed: 11001067
PLoS One. 2018 Jan 17;13(1):e0191358
pubmed: 29342200
Int J Cancer. 2002 Feb 1;97(4):508-11
pubmed: 11802214
Hum Reprod. 2009 Jan;24(1):45-54
pubmed: 18835875
Mol Ther. 2015 Feb;23(2):330-8
pubmed: 25373520
Trends Immunol. 2010 Jun;31(6):220-7
pubmed: 20538542
Int J Cancer. 2003 Oct 10;106(6):905-12
pubmed: 12918068
Scand J Immunol. 2003 Dec;58(6):607-12
pubmed: 14636416
Oncotarget. 2017 Jun 6;8(23):37783-37795
pubmed: 28384121
Lung Cancer. 1996 Dec;16(1):47-59
pubmed: 9017584
Cancer. 2008 Feb 15;112(4):863-75
pubmed: 18203207
J Reprod Immunol. 1998 Aug;39(1-2):197-213
pubmed: 9786462
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83
pubmed: 17360654
Br J Cancer. 2012 May 22;106(11):1833-41
pubmed: 22617157
Blood. 2003 Jul 1;102(1):184-91
pubmed: 12609848
Blood. 2005 Apr 15;105(8):3051-7
pubmed: 15632206
J Clin Invest. 2011 Sep;121(9):3609-22
pubmed: 21841316
J Leukoc Biol. 2006 Sep;80(3):572-80
pubmed: 16816146
Front Oncol. 2014 Jul 02;4:131
pubmed: 25072019
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
FASEB J. 2018 Oct;32(10):5365-5377
pubmed: 29763380
J Clin Invest. 1997 May 1;99(9):2139-51
pubmed: 9151786
Oncogene. 2010 Feb 4;29(5):625-34
pubmed: 19946328
Cell Mol Immunol. 2011 Jan;8(1):1-11
pubmed: 20711229
Urol Res. 2004 Oct;32(5):317-22
pubmed: 15365652
Nature. 2000 Sep 14;407(6801):249-57
pubmed: 11001068
J Clin Oncol. 2003 Jul 1;21(13):2564-73
pubmed: 12829677
PLoS One. 2011;6(9):e22842
pubmed: 21909397
Urol Res. 2002 May;30(2):126-9
pubmed: 12086018